|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Page 174 Onorato is the Chief of the Surveillance, Epidemiology and Investigations Branch, in the Tuberculosis Division and will be presenting on the U.S. Tuberculosis epidemiology and foreign-born Tuberculosis in the United States. In previous discussions I have asked them to avoid encyclopedic “data dumps” and to try to highlight what they see as the key issues for the committee. | ||||||||||||||||
| 10:45 a.m. | ||||||||||||||||
| Break | ||||||||||||||||
| 11:00 a.m. | ||||||||||||||||
| TB Research Ann Ginsberg, National Institutes of Health Dr. Ginsberg is the program officer for Tuberculosis projects at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. I have asked her to provide an overview of Tuberculosis research in general, not just what is happening in the National Institutes of Health. I also asked her to avoid an encyclopedic list but to provide a sense of the research priorities, whether work is under way in that area, and where there are research gaps. | ||||||||||||||||
| 11:30 a.m. | ||||||||||||||||
| U.S. Role in Global Tuberculosis Amy Bloom, U.S. Agency for International Development Dr. Bloom is a Centers for Disease Control and Prevention assignee at the U.S. Agency for International Development providing technical support in the Health and Nutrition Division. AID has just recently allocated funds for Tuberculosis program support and has provided limited support to the World Health Organization and I asked her to outline this for the committee.
|
|
|||||||||||||||
